Tower Research Capital (TRC)’s Definitive Healthcare DH Stock Holding History
Bought
Maintained
Sold
Other funds holding DH
BCM
Tower Research Capital (TRC)'s DH Position: Q3 2026 in Review
Tower Research Capital (TRC) increased its Definitive Healthcare (DH) stake by 92% in Q3 2026, buying an estimated $4.42K and bringing the position to 11,235 shares worth $10.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4297.
Tower Research Capital (TRC) first reported a position in DH in Q3 2021 and has held it in 21 quarters since. The position peaked at $426K in Q3 2021. 95 funds tracked by Wall St. Rank hold DH as of Q3 2026.
- Tower Research Capital (TRC) held 11,235 shares of Definitive Healthcare worth $10.2K as of Q3 2026.
- Tower Research Capital (TRC) bought 5,394 Definitive Healthcare shares in Q3 2026, an estimated $4.42K.
- Definitive Healthcare made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #4297 holding.
- Tower Research Capital (TRC) first reported a position in Definitive Healthcare in Q3 2021 and has held it in 21 quarters since.
- Tower Research Capital (TRC)'s Definitive Healthcare position peaked at $426K in Q3 2021.
- 95 funds tracked by Wall St. Rank held Definitive Healthcare as of Q3 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.